Investigations on the interactions of λphage-derived peptides against the SrtA mechanism in Bacillus anthracis

Applied Biochemistry and Biotechnology

Volumn 172, Issue 4, 2014, Pages 1790-1806

  Selvaraj, Chandrabose ^a   Singh, Poonam ^b   Singh, Sanjeev Kumar ^a  

^a ALAGAPPA UNIVERSITY   (India)

^b CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Activator; LPXTG; Peptide; Peptidomimetic; PlyG; SrtA

Indexed keywords

BACTERIA; BIOLOGICAL WEAPONS; ENZYME INHIBITION; SIGNAL TRANSDUCTION;

ACTIVATOR; LPXTG; PEPTIDOMIMETICS; PLYG; SRTA;

PEPTIDES;

SORTASE; SORTASE A; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; BACILLUS ANTHRACIS; BACTERIOPHAGE LAMBDA; COMPETITIVE INHIBITION; COMPUTER MODEL; ENZYME ACTIVITY; ENZYME MECHANISM; NONHUMAN; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN MOTIF; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION;

AMINOACYLTRANSFERASES; ANTI-BACTERIAL AGENTS; BACILLUS ANTHRACIS; BACTERIAL PROTEINS; CYSTEINE ENDOPEPTIDASES; N-ACETYLMURAMOYL-L-ALANINE AMIDASE; PEPTIDES; VIRAL PROTEINS;

EID: 84896281655     PISSN: 02732289     EISSN: 15590291     Source Type: Journal    
DOI: 10.1007/s12010-013-0641-0     Document Type: Article

References (44)

1. Franz, D. R. (2009). Preparedness for an anthrax attack. Molecular Aspects of Medicine, 30, 503-510.
2. Nicholson, W. L., Munakata, N., Horneck, G., Melosh, H. J., & Setlow, P. (2000). Resistance of Bacillus endospores to extreme terrestrial and extraterrestrial environments. Microbiology and Molecular Biology Reviews, 64, 548-572.
3. Klietmann, W. F., & Ruoff, K. L. (2001). Bioterrorism: implications for the clinical microbiologist. Clinical Microbiology Reviews, 14, 364-381. (Pubitemid 32294675)
4. Marraffini, L. A., Dedent, A. C., & Schneewind, O. (2006). Sortases and the art of anchoring proteins to the envelopes of gram-positive bacteria. Microbiology and Molecular Biology Reviews, 70, 192-221.
5. Mazmanian, S. K., Ton-That, H., Su, K., & Schneewind, O. (2002). An iron-regulated sortase anchors a class of surface protein during Staphylococcus aureus pathogenesis. Proceedings of the National Academy of Sciences of the United States of America, 99, 2293-2298. (Pubitemid 34169054)
6. Chopra, I., Hodgson, J., Metcalf, B., & Poste, G. (1997). The search for antimicrobial agents effective against bacteria resistant to multiple antibiotics. Antimicrobial Agents and Chemotherapy, 41, 497-503. (Pubitemid 27098393)
7. Mogridge, J. (2007). Defensive strategies of Bacillus anthracis that promote a fatal disease. Drug Discovery Today Discovery Mechanism, 4, 253-258.
8. Lashley, F. R. (2004). Emerging infectious diseases: vulnerabilities, contributing factors and approaches. Expert Review of Anti-Infective Therapy, 2, 299-316.
9. Ormala, A. M., & Jalasvuori, M. (2013). Phage therapy: should bacterial resistance to phages be a concern, even in the long run? Bacteriophage, 3, e24219.
10. Burrowes, B., Harper, D. R., Anderson, J., McConville, M., & Enright, M. C. (2011). Bacteriophage therapy: potential uses in the control of antibiotic-resistant pathogens. Expert Review of Anti-Infective Therapy, 9, 775-785.
11. Schuch, R., Nelson, D., & Fischetti, V. A. (2002). A bacteriolytic agent that detects and kills Bacillus anthracis. Nature, 418, 884-889. (Pubitemid 34966308)
12. Rosovitz, M. J., & Leppla, S. H. (2002). Virus deals anthrax a killer blow. Nature, 418, 825-826. (Pubitemid 34966287)
13. Schuch, R., Pelzek, A. J., Raz, A., Euler, C. W., Ryan, P. A., Winer, B. Y., Farnsworth, A., Bhaskaran, S. S., Stebbins, C. E., Xu, Y., Clifford, A., Bearss, D. J., Vankayalapati, H., Goldberg, A.R., & Fischetti, V.A. (2013). Use of a bacteriophage lysin to identify a novel target for antimicrobial development. PLoS One, 8, e60754.
14. Kikkawa, H. S., Ueda, T., Suzuki, S., & Yasuda, J. (2008). Characterization of the catalytic activity of the gamma-phage lysin, PlyG, specific for Bacillus anthracis. FEMS Microbiology Letters, 286, 236-240.
15. Fujinami, Y., Hirai, Y., Sakai, I., Yoshino, M., & Yasuda, J. (2007). Sensitive detection of Bacillus anthracis using a binding protein originating from gamma-phage. Microbiology and Immunology, 51, 163-169. (Pubitemid 46294195)
16. Fischetti, V. A. (2005). Bacteriophage lytic enzymes: novel anti-infectives. Trends in Microbiology, 13, 491-496.
17. Mo, K. F., Li, X., Li, H., Low, L. Y., Quinn, C. P., & Boons, G. J. (2012). Endolysins of Bacillus anthracis bacteriophages recognize unique carbohydrate epitopes of vegetative cell wall polysaccharides with high affinity and selectivity. Journal of the American Chemical Society, 134, 15556-15562.
18. Hermoso, J. A., Garcia, J. L., & Garcia, P. (2007). Taking aim on bacterial pathogens: from phage therapy to enzybiotics. Current Opinion in Microbiology, 10, 461-472. (Pubitemid 350064581)
19. Ganguly, J., Low, L. Y., Kamal, N., Saile, E., Forsberg, L. S., Gutierrez-Sanchez, G., Hoffmaster, A. R., Liddington, R., Quinn, C. P., Carlson, R. W., & Kannenberg, E. L. (2013). The secondary cell wall polysaccharide of Bacillus anthracis provides the specific binding ligand for the C-terminal cell wallbinding domain of two phage endolysins, PlyL and PlyG. Glycobiology, 23, 820-832.
20. Davison, S., Couture-Tosi, E., Candela, T., Mock, M., & Fouet, A. (2005). Identification of the Bacillus anthracis (gamma) phage receptor. Journal of Bacteriology, 187, 6742-6749. (Pubitemid 41356248)
21. Low, L. Y., Yang, C., Perego, M., Osterman, A., & Liddington, R. (2011). Role of net charge on catalytic domain and influence of cell wall binding domain on bactericidal activity, specificity, and host range of phage lysins. The Journal of Biological Chemistry, 286, 34391-34403.
22. Ton-That, H., Marraffini, L. A., & Schneewind, O. (2004). Protein sorting to the cell wall envelope of Gram-positive bacteria. Biochimica et Biophysica Acta, 1694, 269-278. (Pubitemid 39535074)
23. Dramsi, S., Trieu-Cuot, P., & Bierne, H. (2005). Sorting sortases: a nomenclature proposal for the various sortases of Gram-positive bacteria. Research in Microbiology, 156, 289-297. (Pubitemid 40487449)
24. Ton-That, H., & Schneewind, O. (2004). Assembly of pili in Gram-positive bacteria. Trends in Microbiology, 12, 228-234. (Pubitemid 38534627)
25. Hendrickx, A. P., Budzik, J. M., Oh, S. Y., & Schneewind, O. (2011). Architects at the bacterial surface- sortases and the assembly of pili with isopeptide bonds. Nature Reviews Microbiology, 9, 166-176.
26. Bhasin, M., & Raghava, G. P. (2004). SVMbased method for predicting HLA-DRB1*0401 binding peptides in an antigen sequence. Bioinformatics, 20, 421-423. (Pubitemid 38262776)
27. Weiner, E. M., Robson, S., Marohn, M., & Clubb, R. T. (2010). The Sortase A enzyme that attaches proteins to the cell wall of Bacillus anthracis contains an unusual active site architecture. The Journal of Biological Chemistry, 285, 23433-23443.
28. Reddy, K. K., Singh, S. K., Tripathi, S. K., & Selvaraj, C. (2013). Identification of potential HIV-1 integrase strand transfer inhibitors: in silico virtual screening and QM/MM docking studies. SAR and QSAR in Environmental Research, 24, 581-595.
29. Georgiev, V., Noack, H., Borowski, T., Blomberg, M. R., & Siegbahn, P. E. (2010). DFT study on the catalytic reactivity of a functional model complex for intradiol-cleaving dioxygenases. The Journal of Physical Chemistry. B, 114, 5878-5885.
30. Pissarnitski, D.A., Asberom, T., Bara, T. A., Buevich, A.V., Clader, J.W., Greenlee, W. J., Guzik, H. S., Josien, H. B., Li, W., McEwan, M., McKittrick, B. A., Nechuta, T. L., Parker, E. M., Sinning, L., Smith, E. M., Song, L., Vaccaro, H. A., Voigt, J. H., Zhang, L., Zhang, Q., & Zhao, Z. (2007). 2,6-Disubstituted N-arylsulfonyl piperidines as gamma-secretase inhibitors. Bioorganic and Medicinal Chemistry Letters, 17, 57-62. (Pubitemid 44959986)
31. Fu, J., Si, P., Zheng, M., Chen, L., Shen, X., Tang, Y., & Li, W. (2012). Discovery of new non-steroidal FXR ligands via a virtual screening workflow based on Phase shape and induced fit docking. Bioorganic and Medicinal Chemistry Letters, 22, 6848-6853.
32. Abell, A. D., Jones, M. A., Neffe, A. T., Aitken, S. G., Cain, T. P., Payne, R. J., McNabb, S. B., Coxon, J.M., Stuart, B. G., Pearson, D., Lee, H. Y., &Morton, J. D. (2007). Investigation into the P3 binding domain of m-calpain using photoswitchable diazo- and triazene-dipeptide aldehydes: new anticataract agents. Journal of Medicinal Chemistry, 50, 2916-2920. (Pubitemid 46980862)
33. Selvaraj, C., Singh, S. K., Tripathi, S. K., Reddy, K. K., & Rama, M. (2012). In silico screening of indinavir-based compounds targeting proteolytic activity in HIV PR: binding pocket fit approach. Medicinal Chemistry Research, 21, 4060-4068.
34. Das, D., Koh, Y., Tojo, Y., Ghosh, A. K., & Mitsuya, H. (2009). Prediction of potency of protease inhibitors using free energy simulations with polarizable quantum mechanics-based ligand charges and a hybrid water model. Journal of Chemical Information and Modeling, 49, 2851-2862.
35. Tripathi, S. K., Singh, S. K., Singh, P., Chellaperumal, P., Reddy, K. K., & Selvaraj, C. (2012). Exploring the selectivity of a ligand complex with CDK2/CDK1: a molecular dynamics simulation approach. Journal of Molecular Recognition, 25, 504-512.
36. Selvaraj, C. and Singh, S. K. Validation of potential inhibitors for SrtA against Bacillus anthracis by combined approach of ligand-based and molecular dynamics simulation. J Biomol Struct Dyn. doi:10.1080/07391102.2013.818577
37. Shafreen, R. M., Selvaraj, C., Singh, S. K., & Pandian, S. K. (2013). Exploration of fluoroquinolone resistance in Streptococcus pyogenes: comparative structure analysis of wild-type and mutant DNA gyrase. Journal of Molecular Recognition, 26, 276-285.
38. Pronk, S., Pall, S., Schulz, R., Larsson, P., Bjelkmar, P., Apostolov, R., Shirts, M. R., Smith, J. C., Kasson, P. M., van der Spoel, D., Hess, B., & Lindahl, E. (2013). GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit. Bioinformatics, 29, 845-854.
39. Dearden, J. C. (2003). In silico prediction of drug toxicity. Journal of Computer-Aided Molecular Design, 17, 119-127.
40. Cronin, M. T. (2001). Prediction of drug toxicity. Farmaco, 56, 149-151.
41. Mombelli, E. (2008). An evaluation of the predictive ability of the QSAR software packages, DEREK, HAZARDEXPERT and TOPKAT, to describe chemically-induced skin irritation. Alternatives to Laboratory Animals, 36, 15-24.
42. Vijayalakshmi, P., Selvaraj, C., Singh, S. K., Nisha, J., Saipriya, K., & Daisy, P. (2012). Exploration of the binding of DNA binding ligands to Staphylococcal DNA through QM/MMdocking and molecular dynamics simulation. Journal of Biomolecular Structure and Dynamics, 31, 561-571.
43. Dimitrov, I., Flower, D. R. and Doytchinova, I. (2013) AllerTOP-a server for in silico prediction of allergens. BMC Bioinformatics, 14 Suppl 6, S4.
44. Huang, L., & Chen, C. H. (2009). Proteasome regulators: activators and inhibitors. Current Medicinal Chemistry, 16, 931-939.